Stockscreener 앱 받기
1.50
3.45%
0.05
시간 외 거래:
1.53
0.03
+2.00%
전일 마감가:
$1.45
열려 있는:
$1.47
하루 거래량:
584.40K
Relative Volume:
3.54
시가총액:
$24.11M
수익:
-
순이익/손실:
$-8.29M
주가수익비율:
-2.1429
EPS:
-0.7
순현금흐름:
$-6.47M
1주 성능:
+9.49%
1개월 성능:
+4.17%
6개월 성능:
+12.78%
1년 성능:
+0.67%
1일 변동 폭
$1.45
$1.63
1주일 범위
$1.30
$1.63
52주 변동 폭
$0.94
$1.9195
NanoViricides Inc Stock (NNVC) Company Profile
명칭
NanoViricides Inc
전화
203-937-6137
주소
1 Controls Drive, Shelton, CT
NNVC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.50 | 25.27M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-02-11 | 개시 | Midtown Partners | Strong Buy |
NanoViricides Inc 주식(NNVC)의 최신 뉴스
How institutional ownership impacts NanoViricides Inc. stock2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com
NanoViricides Dual Track Clinical Strategy Explained by a Research ReportBroad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses - Norwich Bulletin
NanoViricides Advances Dual-Track Clinical Strategy for Broad-Spectrum Antiviral Drug Candidate NV-387 - citybuzz -
Identifying reversal signals in NanoViricides Inc.July 2025 Retail & Consistent Profit Trade Alerts - newser.com
Understanding NanoViricides Inc.’s price movementWeekly Investment Report & Long-Term Safe Return Strategies - newser.com
Detecting price anomalies in NanoViricides Inc. with AI2025 Volatility Report & Weekly Hot Stock Watchlists - newser.com
Phase II start by late CY25/early CY26: NanoViricides' NV-387 pursues MPox and broad respiratory virus trials - Stock Titan
Is NanoViricides Inc. stock ideal for retirement investorsJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Nanoviricides: Dual track clinical development during 2026Preview | NYSE-A:NNVC - Proactive financial news
How NanoViricides Inc. (NV3P) stock trades after rate cutsMarket Volume Summary & Low Risk Profit Maximizing Plans - newser.com
News impact scoring models applied to NanoViricides Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
Can NanoViricides Inc. (NV3P) stock attract ESG investments2025 Price Targets & Capital Protection Trade Alerts - newser.com
Using data filters to optimize entry into NanoViricides Inc.Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com
NanoViricides, Inc. Has Filed its Annual Report - The Daily Jeffersonian
Is NanoViricides Inc. stock in buy zone after pullbackMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Exit strategy if you’re trapped in NanoViricides Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Why global investors buy NanoViricides Inc. stockTake Profit & Weekly Breakout Watchlists - newser.com
Is NanoViricides Inc. (NV3P) stock a safe buy pre earnings2025 Winners & Losers & Free Safe Capital Growth Stock Tips - newser.com
Using Bollinger Bands to evaluate NanoViricides Inc.July 2025 Review & Reliable Price Breakout Alerts - newser.com
How to read the order book for NanoViricides Inc.2025 Volatility Report & Daily Oversold Bounce Ideas - newser.com
Is NanoViricides Inc. (NV3P) stock undervalued by metricsExit Point & Risk Controlled Swing Alerts - newser.com
Trend analysis for NanoViricides Inc. this weekPortfolio Value Report & Safe Entry Momentum Tips - newser.com
NanoViricides Inc (AMEX: NNVC) stock has achieved $1.4600 in the past week - fostersleader.com
What makes NanoViricides Inc. stock appealing to growth investorsJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
NanoViricides Inc (NNVC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):